购物车
您的购物车当前为空
GIP/GLP-1 dual receptor agonist-1 (Compound 4) (sodium) 是一种GIP/GLP-1受体激动剂,可用于研究代谢紊乱和脂肪肝疾病,包括非酒精性脂肪性肝炎 (NASH) 和非酒精性脂肪性肝病 (NAFLD)。
GIP/GLP-1 dual receptor agonist-1 (Compound 4) (sodium) 是一种GIP/GLP-1受体激动剂,可用于研究代谢紊乱和脂肪肝疾病,包括非酒精性脂肪性肝炎 (NASH) 和非酒精性脂肪性肝病 (NAFLD)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
| 产品描述 | GIP/GLP-1 dual receptor agonist-1 (Compound 4) (sodium) functions as a GIP/GLP-1 receptor agonist. This compound is applicable for research into metabolic disorders and liver diseases, including non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD). |
| Sequence | Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{Lys(AEEA-AEEA-γGlu-C19 phosphoric acid)}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| Sequence Short | Y-{Aib}-EGTFTSDYSI-{Aib}-LDKIAQ-{Lys(AEEA-AEEA-γGlu-C19 phosphoric acid)}-AFVQWLIAGGPSSGAPPPS |
| 存储 |
对于不同动物的给药剂量换算,您也可以参考 更多